Drug name - Twirla

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9050348 AGILE Dermal delivery device Jul, 2028

(5 years from now)

US8747888 AGILE Dermal delivery device with in situ seal Jul, 2028

(5 years from now)

US8246978 AGILE Dermal delivery device with reduced loss of its volatile components Aug, 2028

(5 years from now)

More Information on Dosage
Strength Dosage Availability
0.03MG/24HR;0.12MG/24HR SYSTEM;TRANSDERMAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.